
What have we learned—and what do we need to know—about the mental health implications of organizational and governmental dictatorships?

What have we learned—and what do we need to know—about the mental health implications of organizational and governmental dictatorships?

What neuromodulation can be used to specifically target nicotine users with schizophrenia? This research may tell us.

This ACNP 2023 Annual Meeting poster covered a 26-week study on cariprazine as an adjunctive treatment to antidepressants in patients with major depressive disorder.

The Psymatic Treatment Optimizer facilitates selecting agents ranked by adverse-effect profile with consideration of patient preference and tolerance.

Can the foundations of psychotherapy provide insight into today's conflict?

Neurosteroid therapeutics could be the solution to provide fast-acting treatment for mothers with postpartum depression.

Check out these brief summaries on cognitive impairment in schizophrenia from an excellent session at the ACNP 2023 Annual Meeting!

“This book is an original piece of psychiatric treatment didactics that has very useful characteristics for the benefit of well-motivated patients and conscientious mental health professionals.”

DBS in psychiatry: What challenges stand between this treatment and success? Alik Widge, MD, PhD, shares more at the ACNP 2023 Annual meeting.

Research demonstrates a seasonal trend associated with stroke onset. More strokes occur between November and February than any other time period. Due to the holidays and other events, these months can be stressful and disrupt usual routines. Overeating, excessive alcohol intake, physical inactivity, and sleep deprivation frequently accompany the holidays and can increase risk for stroke. Clinicians can educate and provide strategies to effectively navigate the holiday season and potentially reduce risk for stroke.

Did you catch the President's Plenary at the ACNP 2023 Annual Meeting?

Navacaprant—a novel, oral, once-daily, highly selective kappa opioid receptor antagonist that is currently in phase 3 development as a monotherapy for major depressive disorder.

From dopamine detoxification for problem gaming to connections between bacteria and anxiety and depression, here are highlights from the week in Psychiatric Times.

What is new in research on bipolar disorder?

What is the psychiatrist’s role in climate change? One reader responds.

How can we offer options and hope for the future to patients with treatment-resistant depression?


How can you learn from, appreciate, and grieve for other cultures?


2023 World AIDS Day looks to remember those who have been lost and a renewed commitment to supporting patients with HIV/AIDS.

The results suggest that the bacterium Lactobacillus may aid in the management of stress and in the prevention of these disorders.

The experts weighed in on a wide variety of psychiatric issues for the November 2023 issue of Psychiatric Times.

Here are some updates from the world of psychiatry throughout the month of November.

The FDA’s decision is set for September 2024.

Rosalynn Carter’s life can serve as an example to us all.
How does one heal? Perhaps by "degrees of revealedness," according to a psychiatrist's reflections.

Examine this case in which a patient presents with extreme constipation.

How do specific calendar days impact mental health?

Problematic gaming is often recognized in clinical practice, but can be challenging to treat. Here’s what you can do.

From late-life treatment-resistant depression to the mental health benefits of gratitude, here are highlights from the week in Psychiatric Times.